Cargando…
Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012163/ https://www.ncbi.nlm.nih.gov/pubmed/33811939 http://dx.doi.org/10.1016/j.jinf.2021.03.025 |
| _version_ | 1783673324379832320 |
|---|---|
| author | Tré-Hardy, Marie Cupaiolo, Roberto Papleux, Emmanuelle Wilmet, Alain Horeanga, Alexandra Antoine-Moussiaux, Thomas Della Vecchia, Andrea Beukinga, Ingrid Vekemans, Marc Blairon, Laurent |
| author_facet | Tré-Hardy, Marie Cupaiolo, Roberto Papleux, Emmanuelle Wilmet, Alain Horeanga, Alexandra Antoine-Moussiaux, Thomas Della Vecchia, Andrea Beukinga, Ingrid Vekemans, Marc Blairon, Laurent |
| author_sort | Tré-Hardy, Marie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8012163 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80121632021-04-01 Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers Tré-Hardy, Marie Cupaiolo, Roberto Papleux, Emmanuelle Wilmet, Alain Horeanga, Alexandra Antoine-Moussiaux, Thomas Della Vecchia, Andrea Beukinga, Ingrid Vekemans, Marc Blairon, Laurent J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2021-08 2021-04-01 /pmc/articles/PMC8012163/ /pubmed/33811939 http://dx.doi.org/10.1016/j.jinf.2021.03.025 Text en © 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Tré-Hardy, Marie Cupaiolo, Roberto Papleux, Emmanuelle Wilmet, Alain Horeanga, Alexandra Antoine-Moussiaux, Thomas Della Vecchia, Andrea Beukinga, Ingrid Vekemans, Marc Blairon, Laurent Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers |
| title | Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers |
| title_full | Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers |
| title_fullStr | Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers |
| title_full_unstemmed | Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers |
| title_short | Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers |
| title_sort | reactogenicity, safety and antibody response, after one and two doses of mrna-1273 in seronegative and seropositive healthcare workers |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012163/ https://www.ncbi.nlm.nih.gov/pubmed/33811939 http://dx.doi.org/10.1016/j.jinf.2021.03.025 |
| work_keys_str_mv | AT trehardymarie reactogenicitysafetyandantibodyresponseafteroneandtwodosesofmrna1273inseronegativeandseropositivehealthcareworkers AT cupaioloroberto reactogenicitysafetyandantibodyresponseafteroneandtwodosesofmrna1273inseronegativeandseropositivehealthcareworkers AT papleuxemmanuelle reactogenicitysafetyandantibodyresponseafteroneandtwodosesofmrna1273inseronegativeandseropositivehealthcareworkers AT wilmetalain reactogenicitysafetyandantibodyresponseafteroneandtwodosesofmrna1273inseronegativeandseropositivehealthcareworkers AT horeangaalexandra reactogenicitysafetyandantibodyresponseafteroneandtwodosesofmrna1273inseronegativeandseropositivehealthcareworkers AT antoinemoussiauxthomas reactogenicitysafetyandantibodyresponseafteroneandtwodosesofmrna1273inseronegativeandseropositivehealthcareworkers AT dellavecchiaandrea reactogenicitysafetyandantibodyresponseafteroneandtwodosesofmrna1273inseronegativeandseropositivehealthcareworkers AT beukingaingrid reactogenicitysafetyandantibodyresponseafteroneandtwodosesofmrna1273inseronegativeandseropositivehealthcareworkers AT vekemansmarc reactogenicitysafetyandantibodyresponseafteroneandtwodosesofmrna1273inseronegativeandseropositivehealthcareworkers AT blaironlaurent reactogenicitysafetyandantibodyresponseafteroneandtwodosesofmrna1273inseronegativeandseropositivehealthcareworkers |